• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.鉴定人生长抑素受体亚型 2 配体结合和 G 蛋白信号转导相关的关键残基。
Endocrinology. 2012 Jun;153(6):2747-55. doi: 10.1210/en.2011-1662. Epub 2012 Apr 11.
2
Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.生长抑素受体亚型2中第89位残基处的天冬氨酸突变可阻止Na⁺对激动剂结合的调节,但不改变受体与G蛋白的结合。
Mol Pharmacol. 1993 Aug;44(2):380-4.
3
Somatostatin and its receptor family.生长抑素及其受体家族。
Front Neuroendocrinol. 1999 Jul;20(3):157-98. doi: 10.1006/frne.1999.0183.
4
Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2.Giα3和G(o)α选择性地与克隆的生长抑素受体亚型SSTR2结合。
J Biol Chem. 1993 May 25;268(15):10721-7.
5
Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding.生长抑素受体亚型3第三个跨膜结构域中的天冬氨酸残基124对于生长抑素-14的结合至关重要。
DNA Cell Biol. 1995 Nov;14(11):939-44. doi: 10.1089/dna.1995.14.939.
6
Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.生长抑素受体亚型5的共表达影响生长抑素受体亚型2的内化和转运。
Endocrinology. 2007 May;148(5):2095-105. doi: 10.1210/en.2006-1266. Epub 2007 Feb 1.
7
GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.G 蛋白偶联受体生长抑素受体细胞外环 2 是在胰腺神经内分泌肿瘤 BON 细胞系中产生具有激动剂样活性的亚型选择性抗体的关键外显子。
Pancreas. 2010 Nov;39(8):1155-66. doi: 10.1097/MPA.0b013e3181de8c05.
8
Characterization of cloned somatostatin receptors SSTR4 and SSTR5.克隆的生长抑素受体SSTR4和SSTR5的特性分析
Mol Pharmacol. 1993 Aug;44(2):385-92.
9
Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.对生长抑素-28具有优先亲和力的人类生长抑素受体(5型生长抑素受体)的分子克隆、功能特性及染色体定位
Mol Pharmacol. 1994 Mar;45(3):417-27.
10
alpha-Tocopherol decreases the somatostatin receptor-effector system and increases the cyclic AMP/cyclic AMP response element binding protein pathway in the rat dentate gyrus.α-生育酚可降低大鼠齿状回中的生长抑素受体效应系统,并增强环磷酸腺苷/环磷酸腺苷反应元件结合蛋白信号通路。
Neuroscience. 2009 Aug 4;162(1):106-17. doi: 10.1016/j.neuroscience.2009.04.047. Epub 2009 Apr 22.

引用本文的文献

1
Insulinoma with suspected mutant somatostatin receptor expression according to histological examination.根据组织学检查,怀疑胰岛素瘤存在突变的生长抑素受体表达。
Clin Case Rep. 2024 Nov 5;12(11):e9390. doi: 10.1002/ccr3.9390. eCollection 2024 Nov.
2
Regulation of NS5B Polymerase Activity of Hepatitis C Virus by Target Specific Phytotherapeutics: An In-Silico Molecular Dynamics Approach.靶向特异性植物疗法对丙型肝炎病毒NS5B聚合酶活性的调控:一种计算机模拟分子动力学方法
Cell Biochem Biophys. 2024 Sep;82(3):2473-2492. doi: 10.1007/s12013-024-01359-w. Epub 2024 Jul 23.
3
Plasticity in ligand recognition at somatostatin receptors.生长抑素受体配体识别的可塑性。
Nat Struct Mol Biol. 2022 Mar;29(3):210-217. doi: 10.1038/s41594-022-00727-5. Epub 2022 Feb 24.
4
Understanding the influence of lipid bilayers and ligand molecules in determining the conformational dynamics of somatostatin receptor 2.了解脂质双层和配体分子在确定生长抑素受体 2 构象动力学中的影响。
Sci Rep. 2021 Apr 7;11(1):7677. doi: 10.1038/s41598-021-87422-5.
5
Radiolabeling strategies for radionuclide imaging of stem cells.放射性核素标记干细胞成像的策略。
Stem Cell Rev Rep. 2015 Apr;11(2):254-74. doi: 10.1007/s12015-014-9575-3.
6
Nanoparticle ligand presentation for targeting solid tumors.用于靶向实体瘤的纳米颗粒配体展示
AAPS PharmSciTech. 2014 Oct;15(5):1345-54. doi: 10.1208/s12249-014-0143-6. Epub 2014 Jun 14.
7
Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.配体对接进入 G 蛋白偶联受体比较模型的评估和挑战。
PLoS One. 2013 Jul 2;8(7):e67302. doi: 10.1371/journal.pone.0067302. Print 2013.

本文引用的文献

1
Multimodality imaging of gene transfer with a receptor-based reporter gene.基于受体的报告基因的基因转移的多模态成像。
J Nucl Med. 2010 Sep;51(9):1456-63. doi: 10.2967/jnumed.109.063586. Epub 2010 Aug 18.
2
Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.在 DRY 基序中,μ-阿片受体酪氨酸 166(Tyr3.51)的磷酸化降低了激动剂的效能。
Mol Pharmacol. 2010 Mar;77(3):339-47. doi: 10.1124/mol.109.060558. Epub 2009 Dec 3.
3
Somatostatin and somatostatin receptors.生长抑素与生长抑素受体
Results Probl Cell Differ. 2010;50:137-84. doi: 10.1007/400_2009_29.
4
Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.细胞生长抑制和人类2型生长抑素受体的功能受受体异二聚化调节。
Mol Endocrinol. 2008 Oct;22(10):2278-92. doi: 10.1210/me.2007-0334. Epub 2008 Jul 24.
5
Signaling can be uncoupled from imaging of the somatostatin receptor type 2.信号传导可与2型生长抑素受体的成像解偶联。
Mol Imaging. 2007 Nov-Dec;6(6):427-37.
6
Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.生长抑素/生长抑素受体信号传导:磷酸酪氨酸磷酸酶
Mol Cell Endocrinol. 2008 May 14;286(1-2):40-8. doi: 10.1016/j.mce.2007.08.012. Epub 2007 Aug 31.
7
Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.生长抑素受体亚型信号的选择性调节:组成型受体激活的证据。
Mol Endocrinol. 2007 Oct;21(10):2565-78. doi: 10.1210/me.2007-0081. Epub 2007 Jul 3.
8
Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells.稳定转染的A-427人癌细胞中生长抑素受体2型表达的特征分析
Mol Imaging. 2007 Jan-Feb;6(1):56-67.
9
Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.猪生长抑素受体2具有典型的药理学sst2特征,但在同二聚化和内化方面具有独特的动力学特性。
Endocrinology. 2007 Jan;148(1):411-21. doi: 10.1210/en.2006-0920. Epub 2006 Oct 19.
10
Somatostatin receptor imaging for neuroendocrine tumors.神经内分泌肿瘤的生长抑素受体显像
Pituitary. 2006;9(3):243-8. doi: 10.1007/s11102-006-0270-5.

鉴定人生长抑素受体亚型 2 配体结合和 G 蛋白信号转导相关的关键残基。

Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.

机构信息

Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63108-8224, USA.

出版信息

Endocrinology. 2012 Jun;153(6):2747-55. doi: 10.1210/en.2011-1662. Epub 2012 Apr 11.

DOI:10.1210/en.2011-1662
PMID:22495673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3359596/
Abstract

G protein signaling through human somatostatin receptor subtype 2 (SSTR2) is well known, but the amino acids involved in stimulation of intracellular responses upon ligand binding have not been characterized. We constructed a series of point mutants in SSTR2 at amino acid positions 89, 139, and 140 in attempts to disrupt G protein signaling upon ligand binding. The aspartic acid changes at position 89 to either Ala, Leu, or Arg generated mutant receptors with varying expression profiles and a complete inability to bind somatostatin-14 (SST). Mutations to Asp 139 and Arg 140 also led to varying expression profiles with some mutants maintaining their affinity for SST. Mutation of Arg 140 to Ala resulted in a mutated receptor that had a B(max) and dissociation constant (K(d)) similar to wild-type receptor but was still coupled to the G protein as determined in both a cAMP assay and a calcium-release assay. In contrast, mutation of Asp 139 to Asn resulted in a mutated receptor with B(max) and K(d) values that were similar to wild type but was uncoupled from G protein-mediated cAMP signaling, but not calcium release. Thus, we identified mutations in SSTR2 that result in either receptor expression levels that are similar to wild type but is completely ablated for ligand binding or a receptor that maintains affinity for SST and is uncoupled from G protein-mediated cAMP signaling.

摘要

G 蛋白信号通过人类生长抑素受体亚型 2(SSTR2)是众所周知的,但涉及配体结合时刺激细胞内反应的氨基酸尚未得到表征。我们在 SSTR2 的氨基酸位置 89、139 和 140 处构建了一系列点突变体,试图在配体结合时破坏 G 蛋白信号。将位置 89 的天冬氨酸突变为丙氨酸、亮氨酸或精氨酸,生成了具有不同表达谱的突变受体,并且完全无法结合生长抑素-14(SST)。Asp 139 和 Arg 140 的突变也导致了不同的表达谱,一些突变体保持了对 SST 的亲和力。Arg 140 突变为丙氨酸导致突变受体的 B(max)和解离常数(K(d))与野生型受体相似,但在 cAMP 测定和钙释放测定中均与 G 蛋白偶联。相比之下,Asp 139 突变为 Asn 导致突变受体的 B(max)和 K(d)值与野生型相似,但与 G 蛋白介导的 cAMP 信号传递解偶联,但不与钙释放解偶联。因此,我们确定了 SSTR2 中的突变,这些突变导致受体表达水平与野生型相似但完全丧失配体结合能力,或者导致受体保持对 SST 的亲和力但与 G 蛋白介导的 cAMP 信号传递解偶联。